Products / Services
  • Products / Services
  • Companies
  • Buy Leads
Post Buy Requirement

Hemorrhagic Septicemia Vaccine

Listing ID #1579224

  • Supply Type Supplier
Preferred Buyer From : All over the world

Involved in delivering Hemorrhagic Septicemia Vaccine to customers, we have positioned ourselves as a well-known name in the industry. We, as a Supplier and Exporter, offer export quality in a wide....
View More Details
Send Enquiry

Company Information

  • Member Since 10 Years
  • Nature of Business Exporter
  • Year of Establishment 1988

Ask for more detail from the seller

Contact Supplier

Product Details no_img_icon

Involved in delivering Hemorrhagic Septicemia Vaccine to customers, we have positioned ourselves as a well-known name in the industry. We, as a Supplier and Exporter, offer export quality in a wide range appreciated by our customers. Thanks to our distribution network, we deliver the product at your doorstep at your ease and comfort. Our quality remains unquestionable given our excellent record at customer satisfaction.
Description : Hemorrhagic Septicemia  (HS) Vaccine is used for prophylactic measures to control haemorrhagic septicaemia disease caused by Pasteurella multocida infections in cattle, buffaloes, sheep and goats.  
Composition : HS vaccine contains formalin inactivated cultures of Pasteurella multocida (strain P52). The inactivated cultures are further purified and concentrated before adjuvantation with aluminium hydroxide gel.   
Dosage & Administration : 2 ml for all age groups of cattle and buffaloes; 1 ml for all age groups of sheep and goats. For subcutaneous use only. Shake well before use.  
Vaccination Schedule :

  • Primary Vaccination - 6 months of age and above
  • Booster Dose - 6 months after primary vaccination
  • Re-Vaccination -  Annual  


Precautions : Immunize only healthy animals. Malnutrition, infestation with worms, administration of immunosuppressive agents such as corticosteroids or radiotherapy will interfere with the immune response to vaccine.  
Post-vaccination Reactions : Generally, there are no adverse reactions noticed. Occasionally a transient palpable swelling may occur at the site of injection, which will subside in 24-48 hours.  
Storage & Transport : Store and transport the vaccine between 2 and 8oC until use. At no stage should the vaccine be allowed to freeze. Protect from sunlight.  
Shelf Life : 2 years (24 months) from the date of manufacture
Presentation : Multi-dose vial of 100 ml (50 standard cattle doses of 2 ml each)


Company Details close-icon

Brilliant bio pharma limited (bbpl) is a member company of 226 million us$ tgv conglomerate engaged in manufacture of veterinary biologicals and medicines. The group has diverse activities like industrial chemicals, aquaculture, salt , power, health care, hospitality industry, personal care products, veterinary biologicals and medicines. The group has to its credit the awards like “national award for safety”, “national award for environment and the “national award for r&d”.
Brilliant bio pharma limited was set up in 1988 at hyderabad to manufacture and market veterinary biologicals & medicines with the state-of-art facility. All the initial vaccine batches are tested and certified by indian veterinary research institute (ivri). The manufacturing facility is accredited with who gmp and iso 9001-2008 certification.
Mrs. Mourya boda has taken up the reigns of chairperson & managing director, brilliant bio pharma limited in 2005. She holds bachelor’s degree in law and masters in business management. She was the chairperson for young ficci ladies organization, hyderabad chapter (a division of the federation of indian chambers of commerce and industry (ficci)) during the year 2012-2013.
The r&d wing is certified by the nodal agency for certification of industrial r&d facilities in india, viz., department of science & industrial research (dsir), government of india.
The vaccines are manufactured using modern technology. The vaccines are tested and certified for their safety, sterility and potency as per various pharmacopeial standards.
Our niche products are foot and mouth disease vaccine (fmd) and rabies vaccine. The installed capacity of fmd vaccine is 100 million trivalent doses and the expansion plan for 200 million trivalent doses is in the process. The installed capacity of other bacterial vaccines and rabies vaccine is in excess of 55 million doses.
In addition to the vaccines, our product profile includes animal health products such as antibiotics and antibacterials, analgesics & antipyretics, dewormers, ecto parasiticides, feed additives and galactogogues, etc. Bbpl has the capability to formulate any animal health products (medicines) to suit the live stock requirement of the given country.
Bbpl has strong presence in domestic and international market. The products are registered and being exported to various countries in south east asia, gulf, middle east, far east, cis countries, africa and latin america.
  • Nature of Business Manufacturer / Exporter / Supplier
  • Number of Employees 100 - 150
  • Year of Establishment 1988
Tell us your Buy Requirement to Get Instant Response
Tell us what you need?

Looking for Hemorrhagic Septicemia Vaccine?

Quantity
Seller Contact Details
  • Seller Brilliant Bio Pharma Private Limited
  • Address Khairatabad, Hyderabad, Telangana
Waiting for permission
To search by voice, go to your browser settings and allow access to microphone

Allow microphone access to search with voice